Search
Every article we have published, filed by the company it is actually about.
250 articles filed by company
activism CBIZ activist Ryan Bunn urges ending buybacks, issuing equity and resuming bolt-on acquisitions to delever after the $2.3 billion Marcum…
management Braemar Hotels & Resorts is internalizing its management.
GRZ 2026-06-12 commodities Gold Reserve offers exposure to Venezuela’s giant gold mine as the US moves to reopen the country for business.
credit Investcorp Credit Management BDC is framed as a troubled corner of private credit.
BMRMF 2026-05-29 europe SBM, Monaco’s largest company, reaches another all-time high as capital flows back to Europe and boosts the Principality’s property-heavy…
healthcare Theravance Biopharma began a strategic review after a failed Phase 3 trial.
m&a Braemar Hotels & Resorts’ Four Seasons sale prompts updated views on HST.
business models Green Dot creates a standalone banking-as-a-service bank.
Golden Entertainment’s PropCo-OpCo split follows an insufficient management buyout offer.
asia Light & Wonder plans to move its primary stock listing to the Australian Securities Exchange.
m&a Sotherly Hotels buyout creates a preferred-share conversion arbitrage opportunity.
management Braemar Hotels & Resorts initiated a sales process and faces a gross asset management contract.
financials 180 Degree Capital plans to merge with Mount Logan Capital and launch a tender offer, leaving open questions around the transaction.
equities Mural Oncology update.
real estate Franklin Street Properties pursues strategic alternatives for its office-property portfolio.
real estate Net Lease Office Properties is a REIT office basket pursuing a spin-off and liquidation.
media GCI Liberty trades cheaply, holds tax assets, and faces investor fatigue with John Malone.
financials NSTS Bancorp’s three-year thrift-conversion anniversary could clear the way for a potential sale.
healthcare Kronos Bio’s Tang buyout includes a contingent value right with unusual consideration terms.
healthcare Repare Therapeutics faces a broken biotech valuation and potential strategic alternatives.
healthcare Mural Oncology is a former spin-off biotech now described as broken.
equities Elevation Oncology is a broken biotech with a slightly riskier setup.
financials Dun & Bradstreet’s strategic process is wrapping up as the company trades at a cheap valuation.
healthcare Third Harmonic Bio is pursuing strategic alternatives while preserving options for its THB335 program.
